These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3867798)

  • 41. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal failure services.
    McCarthy M
    Health Serv Manage; 1988 Jun; 84(3):17-9. PubMed ID: 10302548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Substitutes for renal function. Technical trends and logistics of treatment].
    Legrain M; Rottembourg J
    C R Seances Soc Biol Fil; 1981; 175(5):669-93. PubMed ID: 6456794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can hemodialysis remove the factor that suppresses platelet cyclo-oxygenase activity in uremic patients?
    Tanaka H; Umimoto K; Izumi N; Maekawa T; Kishimoto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():552-5. PubMed ID: 3939277
    [No Abstract]   [Full Text] [Related]  

  • 45. Success of the peritoneal dialysis programme in Hong Kong.
    Li PK; Szeto CC
    Nephrol Dial Transplant; 2008 May; 23(5):1475-8. PubMed ID: 18303111
    [No Abstract]   [Full Text] [Related]  

  • 46. [Present significance of home hemodialysis].
    Ota K
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1653-7. PubMed ID: 8537719
    [No Abstract]   [Full Text] [Related]  

  • 47. Home therapy for kidney disease. Continuous ambulatory peritoneal dialysis and continuous cyclic peritoneal dialysis.
    Schreiber MJ; Vidt DG; Cunningham RJ
    Cleve Clin Q; 1985; 52(3):291-7. PubMed ID: 4064309
    [No Abstract]   [Full Text] [Related]  

  • 48. PD takes a big jump in 2014, while HHD shows progress.
    Neumann ME
    Nephrol News Issues; 2014 Sep; 28(10):14, 17, 34. PubMed ID: 25306844
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical and metabolic aspects of chronic peritoneal dialysis.
    Andersen KE
    Scand J Urol Nephrol Suppl; 1983; 74():1-105. PubMed ID: 6364335
    [No Abstract]   [Full Text] [Related]  

  • 50. The best and worst times for dialytic therapy are now.
    Friedman EA
    ASAIO J; 1994; 40(2):107-8. PubMed ID: 8003746
    [No Abstract]   [Full Text] [Related]  

  • 51. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep quality and dialysis efficacy affect functional capacity in patients receiving haemodialysis therapy.
    Sakkas GK; Liakopoulos V; Karatzaferi C; Stefanidis I
    Nephrol Dial Transplant; 2008 Aug; 23(8):2703-4; author reply 2704. PubMed ID: 18463326
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Churchill DN
    Kidney Int Suppl; 1993 Feb; 40():S16-22. PubMed ID: 8445834
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current status of chronic extrarenal purification in France on 31 December 1980. Hemodialysis--peritoneal dialysis--equipment--number of patients treated].
    Méry JP
    Nephrologie; 1982; 3(3):127-32. PubMed ID: 7144996
    [No Abstract]   [Full Text] [Related]  

  • 55. Ischaemic bowel disease in patients on continuous ambulatory peritoneal dialysis.
    Liu HL; Huang JJ; Lan RR; Wang MC; Sung JM; Hsieh RY
    Nephrol Dial Transplant; 1999 Aug; 14(8):2032-4. PubMed ID: 10462296
    [No Abstract]   [Full Text] [Related]  

  • 56. New technology and economic incentives will spur the growth of dialysis at home.
    Goodspeed NB; Sylvester BS
    Caring; 1985 Jan; 4(1):28-34. PubMed ID: 10299994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Home dialysis and the costs of uremia.
    Rennie D
    N Engl J Med; 1978 Feb; 298(7):399-400. PubMed ID: 340948
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ambulatory peritoneal dialysis--benefits, limitations and hopes].
    Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):285-8. PubMed ID: 18634356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis.
    Li PK; Cheung WL; Lui SL; Blagg C; Cass A; Hooi LS; Lee HY; Locatelli F; Wang T; Yang CW; Canaud B; Cheng YL; Choong HL; de Francisco AL; Gura V; Kaizu K; Kerr PG; Kuok UI; Leung CB; Lo WK; Misra M; Szeto CC; Tong KL; Tungsanga K; Walker R; Wong AK; Yu AW;
    Nephrology (Carlton); 2011 Jan; 16(1):53-6. PubMed ID: 21175978
    [No Abstract]   [Full Text] [Related]  

  • 60. Deployment of resources in treatment of end stage renal failure in England and Wales.
    Dowie R
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):988-91. PubMed ID: 6423175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.